Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-07 | Emergent BioSolutions Inc. | Glessner Coleen
(EVP, Quality & Ethics, and CPL) |
F | Common Stock | D | 585 | $2.29 - $2.29 | $1,339 |
2024-04-07 | Emergent BioSolutions Inc. | Hartzel William
(SVP, Bioservices) |
F | Common Stock | D | 665 | $2.29 - $2.29 | $1,522 |
2024-03-05 | Emergent BioSolutions Inc. | Hartzel William
(SVP, Bioservices) |
F | Common Stock | D | 346 | $3.41 - $3.41 | $1,179 |
2024-03-01 | Emergent BioSolutions Inc. | Glessner Coleen
(EVP, Quality & Ethics, and CPL) |
F | Common Stock | D | 381 | $3.39 - $3.39 | $1,291 |
2024-02-29 | Emergent BioSolutions Inc. | Williams Paul Ant...
(SVP, Products Business) |
F | Common Stock | D | 587 | $3.23 - $3.39 | $1,917 |
2024-02-29 | Emergent BioSolutions Inc. | LINDAHL RICHARD S
(EVP, Chief Financial Officer) |
F | Common Stock | D | 9721 | $3.23 - $3.39 | $31,507 |
2024-02-29 | Emergent BioSolutions Inc. | Fox Jennifer Lynne
(EVP, Ext Aff, GC, Corp Sec) |
F | Common Stock | D | 4806 | $3.23 - $3.39 | $15,635 |
2024-02-23 | Emergent BioSolutions Inc. | Williams Paul Ant...
(SVP, Products Business) |
F | Common Stock | D | 105 | $2.74 - $2.74 | $287 |
2024-02-23 | Emergent BioSolutions Inc. | Fox Jennifer Lynne
(EVP, Ext Aff, GC, Corp Sec) |
F | Common Stock | D | 229 | $2.74 - $2.74 | $627 |
2024-02-23 | Emergent BioSolutions Inc. | LINDAHL RICHARD S
(EVP, Chief Financial Officer) |
F | Common Stock | D | 517 | $2.74 - $2.74 | $1,416 |
2024-02-21 | Emergent BioSolutions Inc. | LINDAHL RICHARD S
(EVP, Chief Financial Officer) |
D | Common Stock | D | 4012 | $2.71 - $2.71 | $10,872 |
2023-11-11 | Emergent BioSolutions Inc. | Fox Jennifer Lynne
(EVP, Ext Aff, GC, Corp Sec) |
F | Common Stock | D | 413 | $2.00 - $2.00 | $826 |
2023-11-13 | Emergent BioSolutions Inc. | Williams Paul Ant...
(SVP, Products Business) |
F | Common Stock | D | 566 | $1.82 - $1.82 | $1,030 |
2023-11-11 | Emergent BioSolutions Inc. | Hartzel William
(SVP, Bioservices) |
F | Common Stock | D | 632 | $2.00 - $2.00 | $1,264 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |